Marinomed Biotech AG

Director's Dealing • Feb 22, 2019

Publication Date: 22.02.2019 12:44 EANS-DD: Marinomed Biotech AG / Notification concerning transactions by persons performing managerial responsibilities pursuant to article 19 Market Abuse Regulation (MAR)

Directors' Dealings-Announcement pursuant to artikle 19 MAR transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

personal data: responsible party: name: Simon Nebel (natural person) ------------------------------------------------------------------------------- reason: reason: responsible party is a person with managerial responsibilities function: Chairman of the supervisory board ------------------------------------------------------------------------------- issuer information: name: Marinomed Biotech AG Legal Entity Identifier (LEI): 529900GN3B1EN80XF405 ------------------------------------------------------------------------------- information about deal: ISIN: ATMARINOMED6 description of the financial instrument: Stock type: conversion ISIN AT000A1WD52 date: 20.02.2019; UTC+01:00 market: WIENER BOERSE AG, XWBO currency: Euro price volume 40,87 489 total volume: 489 total price: 19985,43 average price: 40,87 -------------------------------------------------------------------------------- end of announcement euro adhoc

---

issuer:	Marinomed Biotech AG
	Veterinärplatz 1
	A-1210 Wien
phone:	0043250774460
FAX:	0043250774493
mail:	office@marinomed.com
WWW:	www.marinomed.com
ISIN:	ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language:	English

	Aussendung übermittelt durch euro adhoc
	The European Investor Relations Service